All terms in GO
| Label | Id | Description |
|---|---|---|
| sterigmatocystin catabolic process | GO_0045574 |
The chemical reactions and pathways resulting in the breakdown of sterigmatocystin, a carcinogenic mycotoxin produced in high yields by strains of the common molds.
|
| sterigmatocystin metabolic process | GO_0045460 |
The chemical reactions and pathways involving sterigmatocystin, a carcinogenic mycotoxin produced in high yields by strains of the common molds.
|
| basophil activation | GO_0045575 |
The change in morphology and behavior of a basophil resulting from exposure to a cytokine, chemokine, soluble factor, or to (at least in mammals) an antigen which the basophil has specifically bound via IgE bound to Fc-epsilonRI receptors.
|
| granulocyte activation | GO_0036230 |
The change in morphology and behavior of a granulocyte resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
|
| mast cell activation | GO_0045576 |
The change in morphology and behavior of a mast cell resulting from exposure to a cytokine, chemokine, soluble factor, or to (at least in mammals) an antigen which the mast cell has specifically bound via IgE bound to Fc-epsilonRI receptors.
|
| myeloid leukocyte activation | GO_0002274 |
A change in the morphology or behavior of a myeloid leukocyte resulting from exposure to an activating factor such as a cellular or soluble ligand.
|
| poly-gamma-glutamate metabolic process | GO_0070500 |
The chemical reactions and pathways involving poly-gamma-glutamate, a polymer of D- and/or L-glutamic acid residues linked by gamma-peptidyl bonds.
|
| regulation of B cell differentiation | GO_0045577 |
Any process that modulates the frequency, rate or extent of B cell differentiation.
|
| regulation of B cell activation | GO_0050864 |
Any process that modulates the frequency, rate or extent of B cell activation.
|
| poly-gamma-glutamate biosynthetic process | GO_0070501 |
The chemical reactions and pathways resulting in the formation of poly-gamma-glutamate, a polymer of D- and/or L-glutamic acid residues linked by gamma-peptidyl bonds.
|
| negative regulation of B cell differentiation | GO_0045578 |
Any process that stops, prevents, or reduces the frequency, rate or extent of B cell differentiation.
|
| capsule poly-gamma-glutamate biosynthetic process | GO_0070502 |
The chemical reactions and pathways resulting in the formation of poly-gamma-glutamate, a polymer of D- and/or L-glutamic acid residues linked by gamma-peptidyl bonds, that forms all or part of a bacterial capsule.
|
| capsule organization | GO_0045230 |
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the capsule, a protective structure surrounding some species of bacteria and fungi.
|
| positive regulation of B cell differentiation | GO_0045579 |
Any process that activates or increases the frequency, rate or extent of B cell differentiation.
|
| selenium-containing prosthetic group metabolic process | GO_0070503 |
The chemical reactions and pathways involving a prosthetic group that contains selenium, as in the selenium-dependent molybdenum hydroxylases. The selenium atom in the prosthetic group is required for enzymatic function but is labile to a variety of treatments.
|
| selenium compound metabolic process | GO_0001887 |
The chemical reactions and pathways involving compounds that contain selenium, such as selenocysteine.
|
| prosthetic group metabolic process | GO_0051189 |
The chemical reactions and pathways involving a prosthetic group, the non-amino acid portion of certain protein molecules. Prosthetic groups may be inorganic or organic and are usually required for the biological activity of the protein.
|
| selenium-containing prosthetic group biosynthetic process | GO_0070504 |
The chemical reactions and pathways resulting in the formation of a prosthetic group that contains selenium, as in the selenium-dependent molybdenum hydroxylases. The selenium atom in the prosthetic group is required for enzymatic function but is labile to a variety of treatments.
|
| prosthetic group biosynthetic process | GO_0051191 |
The chemical reactions and pathways resulting in the formation of a prosthetic group, the non-amino acid portion of certain protein molecules. Prosthetic groups may be inorganic or organic and are usually required for the biological activity of the protein.
|
| pollen coat | GO_0070505 |
A layer of extracellular matrix deposited onto the surface of the pollen wall upon disintegration of the tapetal layer of the anther wall in the late stages of pollen development. The composition of this material is highly heterogeneous and includes waxes, lipid droplets, small aromatic molecules, and proteins. The pollen coat is proposed to have many functions, such as holding pollen in the anther until dispersal, facilitation of pollen dispersal, protection of pollen from water loss and UV radiation, and facilitation of adhesion of pollen to the stigma.
|